Search Results 131-140 of 25503 for actinic keratosis clinical trials
Patients with Acute Myeloid Leukemia (AML) in complete remission will receive eltrombopag while undergoing consolidation chemotherapy with high-dose cytarabine.
Rochester, Minn. Transcranial Magnetic Stimulation (TMS) is an increasingly accepted neurostimulation- based treatment for major depressive disorder. While ...
The second aim is to conduct high-throughput testing of various drugs (e.g., virotherapy, immunotherapy) on these cell lines and 3D tumor models. The completion ...
Patients in the study will be treated with Melphalan/HDS and will receive up to 6 total treatments. This study will evaluate the safety and effects of the ...
The purpose of this study is to identify clinical characteristics and biomarkers predictive of disease outcome, progression, and treatment response in ...
The purpose of this study is to create a comprehensive system of tissue banking of samples from Mayo Clinic Arizona patients with a clinical diagnosis of ...
About this study. This phase II trial studies how well reduced doses of radiation therapy to the brain and spine (craniospinal) and chemotherapy work in ...
Media Requests · News Network · Price Transparency · Medical Professionals · AskMayoExpert · Clinical Trials · Mayo Clinic Alumni Association · Refer a Patient ...
Descriptions. Ingenol topical is used to treat a skin condition called actinic keratosis on the face, scalp, body, arms, or legs.
Learn about clinical trials being conducted at Mayo Clinic to improve the diagnosis, care and outcomes for people with breast conditions.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.